WallStreetZenWallStreetZen

NASDAQ: KYNB
Kyntra Bio Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Kyntra Bio earnings were $163.6M for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. The latest KYNB earnings report on Mar 31, 2026 announced Q1 2026 earnings of -$15.2M, up 6.9% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, KYNB reported annual earnings of $183.5M, with -485.6% growth.

KYNB earnings history

Current Revenue
$7.4M
Current Earnings
$163.6M
Current Profit Margin
2,199.4%

KYNB Return on Equity

Current Company
-208.5%
Current Industry
-142.1%
Current Market
14.1%
KYNB's Return on Equity (-208.5%)... subscribe to Premium to read more.
High Return on Equity Performance

KYNB Return on Assets

Current Company
120.2%
Current Industry
-13.5%
KYNB is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when KYNB announces earnings.

KYNB Return on Capital Employed

Current Company
211.56%
Current Industry
-9.4%
KYNB has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

KYNB vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
KYNB$172.88M$163.62MN/A$40.44
LITS-$60.82M-$60.82MN/A-$2.00
CRVO-$30.04M-$30.04MN/A-$3.28
BRNS-$45.03M-$52.31MN/A-$1.29
ALLR-$10.94M-$11.25MN/A-$0.72
View Top Biotech Stocks

Kyntra Bio Earnings Reports & History FAQ

What were Kyntra Bio's earnings last quarter?

Kyntra Bio (NASDAQ: KYNB) reported Q1 2026 earnings per share (EPS) of -$3.76, up 426.96% year over year. Total KYNB earnings for the quarter were -$15.20 million. In the same quarter last year, Kyntra Bio's earnings per share (EPS) was $1.15.

If you're new to stock investing, here's how to buy Kyntra Bio stock.

Is Kyntra Bio profitable or losing money?

As of the last Kyntra Bio earnings report, Kyntra Bio is currently profitable. Kyntra Bio's net profit (also called net income) for the twelve months ending Mar 31, 2026 was $163.62 million, a 1,735.01% decrease year over year.

What was KYNB's earnings growth in the past year?

As of Kyntra Bio's earnings date in Q2 2026, Kyntra Bio's earnings has grown year over year. KYNB earnings in the past year totalled $163.62 million.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.